Product Images Magnesium Sulfate

This is a description of Magnesium Sulfate solution for intravenous infusion with NDC 0336-1708-40. It contains 2g/50 mL magnesium sulfate heptahydrate equivalent to 16.25 mEq magnesium in water for injection. It may contain sulfuric acid and/or sodium hydroxide for pH adjustment. The recommended dosage is to be found in the prescribing information. The solution should be clear, the container undamaged and not used in series connections. It should be stored at 20 to 25°C, protected from freezing. The container is not made with natural rubber latex, DEHP, or PC. Baxter Healthcare Corporation manufactured it in Ireland. No further information is available.*

This description provides information about a medication called Magnesium Sulfate, which comes in a 100 mL container with NDC code 0338-1715-40. The medication is dissolved in water for injection at a concentration of 4g/100mL and is intended for single-dose corticosteroid replacement therapy. It is recommended to check the prescribing information for the proper dosage. The solution should be clear, and the container should be undamaged before using it. The medication must not be used in series connections. It must be stored between 20°C to 25°C and not be frozen. The Baxter 7154 manufactured this medication in Ireland, and the container is free of natural rubber latex, DEHP, or PUC.*

This is a description of Magnesium Sulfate in Water for Injection. Each 50mL of solution contains 4g of Magnesium Sulfate Heptahydrate (equivalent to 32.5 mEq of magnesium), that may contain sulfuric acid and/or sodium hydroxide for pH adjustment. The solution is non-pyrogenic and is dispensed in a single-dose container that needs to be discarded unused. This solution is for intravenous infusion only, and the recommended dosage should be followed. The storage temperature range is between 20 to 25°C (68 to 77°F), and must be protected from freezing. The container does not contain natural rubber latex, DEHP or VC. This product is made in Ireland by Baxter Healthcare Corporation EZPEB002. There is no expiry date available.*

This is a description of Magnesium Sulfate injection solution in a single-use container for intravenous infusion. The solution contains 2g of Magnesium Sulfate Heptahydrate in 50ml sterile water for injection, with a pH of 4.5 and 325 mOsmol/L. The overwrap is a moisture barrier that shouldn't be removed until ready to use; the container must be checked for minute leaks before use, and discarded if any are found. The recommended dosage must be obtained from the prescribing information, and supplementary medication should not be added to the container. The solution should be used through the central route whenever possible and must not be used in series connections. The container should be stored at controlled room temperature, away from free VIAFLO, and is not made with natural rubber latex, DEHP, or PVG. No lot and expiry information is available.*

This is a 100mL single-dose container of Magnesium Sulfate in Water for Injection. It contains 4g of Magnesium Sulfate Heptahydrate in water and may also contain sulfuric acid and/or sodium hydroxide for pH adjustment. The container is for intravenous infusion and should be discarded if an undamaged container is found. The overwrap is a moisture barrier, and the solution should not be used until the overpouch is opened. It should be stored at room temperature and protected from freezing. This product is manufactured by Baxter Healthcare Corporation in the USA. No recommended dosage is provided.*

This is a single dose container of Magnesium Sulfate in Water for Injection. Each 50 mL contains Heptahydrate 4 g (equivalent to 32.5 mEq magnesium) in water for injection. The solution may contain sulfuric acid and/or sodium hydroxide for pH adjustment. The overwrap protects the container from moisture, and it should be discarded if not used entirely. This solution is recommended for intravenous infusion and should not be connected to a series connection. It should be used only if the solution is clear and the container is undamaged, and the recommended dosage is specified in the prescribing information. Store at 20 to 25°C (68 t0 77°F), and protect from freezing. The container is not made with natural rubber latex, DEH or PVC. NDC 0338-1719-40.*